Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1001/archophthalmol.2011.338

Type

Journal article

Journal

Arch Ophthalmol

Publication Date

12/2011

Volume

129

Pages

1626 - 1628

Keywords

Adult, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Bevacizumab, Choroidal Neovascularization, Corneal Dystrophies, Hereditary, Extracellular Matrix Proteins, Female, Fluorescein Angiography, Humans, Intravitreal Injections, Male, Middle Aged, Optic Disk Drusen, Point Mutation, Retrospective Studies, Tomography, Optical Coherence, Vascular Endothelial Growth Factor A, Visual Acuity